Form 4: Teladoc Health Executive Kornwasser Laizer Reports Acquisition of 102,100 Restricted Stock Units

Teladoc Health's President of Enterprise Growth, Kornwasser Laizer, reported acquiring 102,100 restricted stock units on March 19, 2024.

Summary

• On March 19, 2024, Kornwasser Laizer, President of Enterprise Growth at Teladoc Health, acquired 102,100 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Teladoc Health common stock.
• The RSUs vest over time, with one-third vesting on the first anniversary of the grant date.
• The remaining RSUs vest in eight substantially equal quarterly installments beginning on June 1, 2025.
• Following the transaction, Kornwasser Laizer directly owns 102,100 derivative securities.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock unit acquisition, typical for executive compensation. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It provides transparency into the holdings of company insiders.

Stakeholder Impact

• The vesting of restricted stock units aligns the executive's interests with those of the shareholders, incentivizing long-term value creation.

Key Dates